Article
Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.
Cancer medicine - 1 Mar 2023
Shirota Hidekazu, Komine Keigo, Takahashi Masanobu, Takahashi Shin, Miyauchi Eisaku, Niizuma Hidetaka, Tada Hiroshi, Shimada Muneaki, Niihori Tetsuya, Aoki Yoko, Sugiyama Ikuko, Kawamura Maako, Yasuda Jun, Suzuki Shuhei, Iwaya Takeshi, Saito Motonobu, Saito Tsuyoshi, Shibata Hiroyuki, Furukawa Toru, Ishioka Chikashi
Abstract excerpt
BACKGROUND: A paradigm shift has occurred in cancer chemotherapy from tumor-specific treatment with cytotoxic agents to personalized medicine with molecular-targeted drugs. Thus, it is essential to identify genomic alterations and molecular features to recommend effective targeted molecular medicines regardless of the tumor site. Nevertheless, it takes considerable expertise to identify treatment targets from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
